MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $293,000 | -17.2% | 2,000 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $354,000 | +9.6% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $323,000 | -5.8% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $343,000 | -21.9% | 2,000 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $439,000 | +32.2% | 2,000 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $332,000 | +45.6% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $228,000 | -11.6% | 2,000 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $258,000 | +0.8% | 2,000 | -83.3% | 0.00% | +33.3% |
| Q1 2016 | $256,000 | -63.1% | 11,950 | -45.6% | 0.00% | -66.7% |
| Q4 2015 | $694,000 | +1.0% | 21,950 | +10.0% | 0.01% | 0.0% |
| Q3 2015 | $687,000 | +53.7% | 19,950 | +40.5% | 0.01% | +80.0% |
| Q2 2015 | $447,000 | – | 14,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |